本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Merit Medical Systems

84.52
+0.37000.44%
成交量:39.85万
成交额:3,372.35万
市值:50.05亿
市盈率:42.85
高:85.41
开:84.65
低:84.09
收:84.15
52周最高:111.45
52周最低:78.12
股本:5,921.91万
流通股本:5,782.82万
量比:0.96
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):1.97
每股收益(LYR):2.07
净资产收益率:8.60%
总资产收益率:4.19%
市净率:3.36
市盈率(LYR):40.88

数据加载中...

2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities